Pharmafile Logo
Pharmafocus logo
Advanced Search
amgen_flag

FDA to review data on Amgen’s Humira biosimilar

June 14, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Amgen, FDA, Humira, biosimilar

Amgen (NASDAQ: AMGN) has announced the US Food and Drug Administration’s (FDA) Arthritis Advisory Committee will review data supporting the …

News
novo_flag

Novo Nordisk says Victoza lowers risk of heart attacks in diabetes patients

June 14, 2016
Manufacturing and Production, Research and Development Novo Nordisk, Victoza, drug trial, type 2 diabetes

Danish diabetes drugmaker giant Novo Nordisk (NYSE: NVO) on Tuesday said a large study showed its Victoza (liraglutide) reduced the risk of …

News
jcelebi

New COO appointed at X4 Pharmaceuticals

June 13, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

X4 Pharmaceuticals has announced the appointment of John K. Celebi as its new chief operating officer. Celebi will bring over …

Appointment
shire_image_4

Shire gets FDA breakthrough therapy designation for two rare disease drugs

June 13, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Breakthrough Therapy Designation, Shire, US FDA, rare disease, rare disease drugs

Ireland headquartered Shire (LSE: SHP) on Monday said the US Food and Drug Administration (FDA) has granted breakthrough therapy designation …

News
lilly_research_labs_sign

Lilly showcases positive late-stage data in diabetes treatments

June 13, 2016
Research and Development, Sales and Marketing diabetes, lilly

Eli Lilly (NYSE: LLY) has presented data on their diabetes drugs in late-stage trials at the 76th American Diabetes Association …

News
stocks1

Weekly Movers: Lion Biotech, Adamis, Sarepta…

June 13, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Alexion, Biogen, Shares, Stock Markets, Stock Movement, drug trial, sarepta

Drug trial results remained the important theme over the past week with several companies announcing key study results. The trial …

Feature
novo_flag

Novo Nordisk presents Tresiba data showing significantly lower hypoglycaemia rates

June 13, 2016
Research and Development, Sales and Marketing Novo Nordisk, Tresiba

Novo Nordisk (CPH: NOVO-B) has presented new Phase IIIb data on Tresiba (insulin degludec) at the American Diabetes Association annual …

News
ae

Google’s DeepMind to apply artificial intelligence technology to NHS in next five years

June 13, 2016
Medical Communications, Research and Development, Sales and Marketing DeepMind, NHS, collaboration, google, health tech

Google’s artificial intelligence company DeepMind Technologies wants to apply its machine learning technology to NHS patient data within the next …

News

Pfizer’s leukaemia drug beats chemotherapy in Phase III trials

June 13, 2016
Research and Development, Sales and Marketing Inotuzumab ozogamicin, Pfizer, acute lymphoblastic leukaemia

Pfizer (NYSE: PFE) has announced data from a pivotal Phase III trial for acute lymphoblastic leukaemia (ALL) drug, inotuzumab ozogamicin, …

News
globalblood

Shares in Global Blood jump after positive results for trial sickle cell drug

June 13, 2016
Research and Development, Sales and Marketing Global Blood Therapeutics, drug trial, sickle cell disease

Global Blood Therapeutics (Nasdaq: GBT) shares jumped to close up over 9% Friday after the company said its trial drug …

News
humira_abbott__4

EU ombudsman calls for more transparency from AbbVie on Humira

June 10, 2016
Medical Communications, Research and Development AbbVie, EMA, EU, Humira, ombudsman

Abbvie continues to withhold details of clinical trials involving the world’s top-selling prescription medicine, Humira (adalimumab), according to the European …

News
simone_menne

Boehringer Ingelheim names Simone Menne new chief financial officer

June 10, 2016
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

German drugmaker Boehringer Ingelheim has named Simone Menne as its new chief financial officer. The current CFO at Lufthansa will …

Appointment
lab

New high-risk treatment can halt MS, claim researchers

June 10, 2016
Research and Development multiple sclerosis, research

The results of a Phase II clinical trial, published in The Lancet, suggests that a new use of chemotherapy followed …

News

FDA committee recommends MSD’s c. diff prevention drug

June 10, 2016
Medical Communications, Research and Development, Sales and Marketing FDA, MSD, Merck, bezlotoxumab, committee, zinplava

The US Food and Drug Administration’s (FDA) antimicrobial drugs advisory committee has voted by 10 to 5, with one abstention, …

News
merckincweb2

Merck & Co agrees to buy biotech firm Afferent for upfront $500 million in cash

June 10, 2016
Medical Communications, Sales and Marketing Afferent Pharmaceuticals, Financial, M&A, MA, Merck & Co

US drugmaker Merck & Co (NYSE: MRK) said it has agreed to buy biotech firm Afferent Pharmaceuticals for an upfront …

News

Novartis presents strong results in rare blood disorder trials

June 10, 2016
Medical Communications, Research and Development Jakavi, Novartis, Revolade, blood disorder

Novartis has released data from two late-stage trials for rare blood disorders, which showed that Javi (ruxolitinib) is superior to …

News
janssen_latest_logo_on_sign

Janssen says its immunotherapy daratumumab extends progression-free survival in combination study to treat multiple myeloma

June 10, 2016
Medical Communications, Research and Development Janssen, Phase III trials, drug trial, immunotherapy, multiple myeloma

Janssen said late-stage combination trials for its immunotherapy daratumumab increased progression-free survival for patients with multiple myeloma.  The company said …

News

Nice says Bayer’s Eylea not recommended as first-line treatment in draft recommendation

June 10, 2016
Medical Communications, Research and Development Bayer, Eylea, NICE, recommendation, regulation

The National Institute for Health and Care Excellence (Nice) in a provisional guidance said Bayer’s (ETR: BAYN) Eylea (aflibercept) is …

News

FDA targets online illegal prescription drugs sellers

June 10, 2016
Medical Communications, Sales and Marketing FDA, Ireland, illegal drug sales

The US Food and Drug Administration (FDA), in partnership with an INTERPOL-led global collaborative effort, has announced that it has …

News

Amgen, Novartis migraine drug meets primary endpoint in Phase II study

June 9, 2016
Research and Development AMG 334, Amgen, Novartis, Phase II, chronic, erenumab, migraine

A new treatment for chronic migraine prevention, co-developed by Novartis (NYSE: NVS) and Amgen (NASDAQ: AMGN), showed a statistically significant …

News
The Gateway to Local Adoption Series

Latest content

Ofichem brings all brands under single trading name

April 23, 2026

Carvolix strengthens its Board of Directors, advisory board and governance structure

April 23, 2026

Under-Secretary of State for Health Innovation and Safety visits new building on University of Huddersfield’s NHIC

April 22, 2026

Incyclix Bio announces new additions to the Board

April 22, 2026

Remedy Plan Therapeutics Appoints Jotin Marango as CFO and CBO

April 21, 2026